Pluristem and the Alliance for Regenerative Medicine Advocate for Industry Advancement in Washington DC
Pluristem Therapeutics, Inc., a leading developer of placenta-based cell therapies, announced today that Company executives are actively participating in a series of meetings in Washington D.C. regarding proposed legislation that may impact the future of cell therapy and regenerative medicine in the U.S.
View full press release